Stephen B Hanauer MD
Inflammatory Bowel Disease
Medical Director, Digestive Health Center, Northwestern University Feinberg School of Medicine
Join to View Full Profile
676 N Saint Clair StSte 650Chicago, IL 60611
Phone+1 312-695-5620
Fax+1 312-695-2310
Dr. Hanauer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Stephen Hanauer is a gastroenterologist in Chicago, IL and is affiliated with multiple hospitals in the area, including University of Chicago Medical Center and Northwestern Memorial Hospital. He received his medical degree from University of Illinois College of Medicine at Chicago and has been in practice 40 years. He specializes in inflammatory bowel disease and is experienced in general gastroenterology, inflammatory bowel disease, ulcerative colitis, and crohn's disease.
Education & Training
University of ChicagoFellowship, Gastroenterology, 1981 - 1982- University of ChicagoResidency, Internal Medicine, 1977 - 1981
University of Illinois College of MedicineClass of 1977
Certifications & Licensure
FL State Medical License 2024 - Present
IL State Medical License 1978 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- President American College of Gastroenterology, 2014-2015
- America's Top Doctors Castle Connolly, 2002-2014
- Chicago Magazine: Top Doctors Castle Connolly, 2004, 2006, 2008, 2010, 2012, 2014
- Join now to see all
Clinical Trials
- A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease Start of enrollment: 2002 Apr 01
- Imuran Dosing in Crohn's Disease Study Start of enrollment: 2005 Jul 01
- High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease Start of enrollment: 2007 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsAn International Consensus on Appropriate Management of Corticosteroids in Clinical Trials in Inflammatory Bowel Disease.Jurij Hanžel, Virginia Solitano, Sudheer Kumar Vuyyuru, Remo Panaccione, Bruce E Sands
Gastroenterology. 2025-11-01 - 1 citationsThe position of anti-tumor necrosis factor agents for the treatment of adult patients with Crohn's disease.Stephen B Hanauer, Byong Duk Ye, Raymond K Cross, Silvio Danese, Geert D'Haens
Expert Review of Gastroenterology & Hepatology. 2025-07-01 - Impact of Precision-Guided Dosing on Clinical Decision-Making and Health Care Utilization in Inflammatory Bowel Disease: A Retrospective Pretest/Posttest Real-World St...Ronen Arai, Adria Condino, Bincy P Abraham, Stephen B Hanauer, Udayakumar Navaneethan
Crohn's & Colitis 360. 2025-07-01
Authored Content
- DDW 2025: Perspectives on IBDMay 2025
- The Elephant in the GI SystemJune 2024
- IBD Impressions from DDW 2022May 2022
- Personalized Medicine and Telehealth at AIBD 2021December 2021
- An Ode to SteroidsNovember 2021
- IBD: A Focus on BiologicsJune 2021
- My Takes on Virtual AIBD 2020: Perspectives from a Conference ChairDecember 2020
- Here's the Most Important Research from AIBDJanuary 2020
- Here's the Most Important Research from AIBDJanuary 2020
- Join now to see all
Press Mentions
Colonoscopies: They Aren’t Fun, but Having One Could Save Your LifeFebruary 20th, 2025- Mindfulness, CBT Combo Improves Quality of Life in Crohn’sOctober 7th, 2024
- Subcutaneous Infliximab Beats Placebo for IBD Maintenance TherapySeptember 11th, 2024
- Join now to see all
Grant Support
- Multi-Site Trial Of Azathioprine Dosing In Crohn DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2004
- Multi-Site Trial Of Azathioprine Dosing In Crohn DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2003
- Anti-Tnfa MAB (Remicad /Infliximab) In Active Crohn'S DINational Center For Research Resources2000–2002
- Phase II Study Of Bxt 51072 In Patients W/ Ulcerative ColitisNational Center For Research Resources1999–2002
- Cdp571 In Steroid Dependent Patients W/ Crohns DiseaseNational Center For Research Resources1999–2002
- Cdp571 In Moderate To Severe Crohns DiseaseNational Center For Research Resources1999–2002
- ISIS 2302 In Steroid-Dependent Crohn'S DiseaseNational Center For Research Resources1998–2002
- IV PHO IL10 In Patients With Steroid Refractory CrohnsNational Center For Research Resources1996
- Assessment Of Hypothalamic-Pituitary-Adrenal Axis In Inflammatory Bowel DiseaseNational Center For Research Resources1994–1995
- Pharmacokinetic Study Of Rectally Administered Sc-41930 In Ulcerative ColitisNational Center For Research Resources1993–1994
Committees
- Chair, FDA Gastrointestinal Drugs Advisory Committee 2005 - Present
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
